Concentra Group Holdings Parent Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Concentra Group Holdings Parent Inc in the second quarter 2026?
Concentra Group Holdings Parent Inc achieved a return on average equity (ROE) of 48.13 % in its second quarter 2026, this is above CON's average return on equity of 42.1%.
Concentra Group Holdings Parent Inc shareholder's equity over the 12 months ending in its second quarter 2026 are valued at $427 million

ROE has advanced compared to 46.95% in the first quarter 2026, due to net income growth.

Within the Healthcare Facilities industry only one company had a higher return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 207, from total ROE ranking in the first quarter 2026 at 215.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Equity Change	39.36 %	38.33 %	42.86 %	37.99 %	-
Y / Y Net Income Change	45.69 %	28.66 %	58.73 %	8.88 %	-12.94 %
Net Income (TTM) in Millions	206	184	173	159	155
Return On Equity (TTM)	48.13 %	46.95 %	47.62 %	47.9 %	50.78 %
CON's Total Ranking	# 207	# 215	# 180	# 164	# 354
Equity (TTM) in Millions	485	432	401	391	348
Seq. Equity Change	12.15 %	7.78 %	2.65 %	12.32 %	11.32 %
Seq. Net Income Change	28.7 %	44.49 %	-27.36 %	7.85 %	13.66 %

Back to CON Management Effectiveness >> CON's 5 Years Annual ROE >> Compare CON ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 2
Sector	# 38
Overall	# 207

Return On Equity Statistics
High	Average	Low
50.78 %	42.1 %	22.79 %
(Jun 30 2025)		(Dec 31 2024)

CON Annual Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024
Total Equity in Millions	401	281	0	0	0
Y / Y Equity Change	42.86 %	-	-	-	-
Net Income in Millions	173	172	0	0	0
Y / Y Net Income Change	0.55 %	-	-	-	-
Return On Equity	43.1 %	61.24 %	-	-	-

Back to CON Management Effectiveness >> CON's 5 Years Annual ROE >> Compare CON ROE to its Competitors

Annual Roe Comment

In 2025 ROE fell to 43.1 %, despite net income growth.

More Return On Equity Ratios
Healthcare Facilities Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
CON's' Return on Equity at Yahoo Finance
CON's Roe Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for CON's Competitors
Subscribers only: Roe for Concentra Group Holdings Parent Inc 's Suppliers
Subscribers only: Return On Equity for CON's Customers

Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector	ROE
Oncotelic Therapeutics Inc	124.17 %
Fortress Biotech Inc	118.22 %
Medpace Holdings Inc	110.15 %
Pulmatrix Inc	108.83 %
Arbutus Biopharma Corp	106.04 %
Rigel Pharmaceuticals Inc	96.49 %
Exelixis Inc	93.62 %
Alnylam Pharmaceuticals Inc	93.61 %
Eli Lilly And Company	92.54 %
Amgen Inc	89.32 %
Q32 Bio Inc	76.88 %
3m Company	76.55 %
Oramed Pharmaceuticals Inc	73.03 %
Tg Therapeutics Inc	72.30 %
Idexx Laboratories Inc	71.96 %
Elite Pharmaceuticals Inc	71.10 %
Zoetis Inc	68.87 %
Rallybio Corporation	68.56 %
Earth Science Tech Inc	66.17 %
Aurinia Pharmaceuticals Inc	59.00 %
Vaxart Inc	53.04 %
Qhslab Inc	51.21 %
Tenet Healthcare Corp	50.64 %
Nrc Health	48.29 %
Concentra Group Holdings Parent Inc	48.13 %
Bristol myers Squibb Company	46.65 %
Agilent Technologies inc	41.99 %
Eton Pharmaceuticals Inc	40.13 %
Adma Biologics Inc	39.59 %
Dexcom Inc	36.25 %

Date modified: 2026-09-08T17:13:09+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.